Related Experiment Videos
Avoiding inappropriate surgery for secondary rectal cancer.
1Department of Surgery, Wexham Park Hospital, Slough, UK.
Summary
Secondary rectal carcinoma mimics primary tumors, but histology and immunohistochemistry are key differentiators. Avoid abdominoperineal excision; systemic therapy is preferred for metastatic rectal cancer.
Area of Science:
- Oncology
- Gastroenterology
- Pathology
Background:
- Secondary rectal carcinoma arises from local invasion or distant metastases.
- Primary rectal cancer management typically involves surgery, unlike secondary cases.
- Differentiating primary and secondary rectal cancer is crucial to avoid inappropriate surgical interventions.
Purpose of the Study:
- To investigate methods for differentiating primary and secondary rectal carcinoma.
- To identify strategies for avoiding unnecessary surgical procedures, specifically abdominoperineal excision.
Main Methods:
- Retrospective analysis of six patients diagnosed with secondary rectal carcinoma.
- Histology and immunohistochemistry were used for diagnosis.
- Primary tumor origins included prostate, endometrium, and breast.
Main Results:
- Patients presented with lower gastrointestinal symptoms; four had a palpable rectal mass.
- Histology and immunohistochemistry confirmed the diagnosis.
- Treatment involved systemic therapies (endocrine, chemotherapy, radiotherapy) and surgery (palliative or curative). Median survival was 7.5 months.
Conclusions:
- Clinical presentation of primary and secondary rectal carcinoma is similar.
- Histology and immunohistochemistry are essential for accurate diagnosis.
- Prostate-specific antigen (PSA) staining demonstrated 100% accuracy for prostate-origin secondary rectal cancer.
- Systemic therapy is the primary treatment for secondary rectal carcinoma; surgery is generally palliative and abdominoperineal excision should be avoided.